- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Zongertinib Gets Accelerated FDA Nod for HER2 NSCLC
Aug 14, 2025
North America Intravenous Immunoglobulin Market is expected to reach US$ 8,747.81 million by 2030
Oct 10, 2023
Scientists hail dexamethasone as 'major breakthrough' in treating COVID-19
Jun 16, 2020
Purina Pro Plan Announces the First and Only Allergen-Reducing Cat Food
Feb 26, 2020
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019
Cannabis Market is expected to reach US$ 1,99,504.9 million by 2028
Jan 31, 2023
North America Vaccines Market is Estimated to Grow with a CAGR of 6.0% from 2019-2027
Sep 25, 2020
Follow us on
